logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
B

Byron J. Hoogwerf

cleveland clinic foundation

52H指数
235论文数
1.2W被引数
收录论文 83
发表时间
logo
LADA: A case for starting insulin therapy at diagnosisLADA：在诊断时开始胰岛素治疗的案例
errCLEVELAND CLINIC JOURNAL OF MEDICINE
IF4.1
err2025-12-01
err1
PREAI
errHoogwerf, Byron J.
err分享
err收藏
Statins may increase diabetes, but benefit still outweighs risk
errCLEVELAND CLINIC JOURNAL OF MEDICINE
IF4.1
err2023-01-03
err12
errOAAI
errHoogwerf, Byron J.
err分享
err收藏
Prediabetes, Atrial Fibrillation, and Heart Failure: An Intersection of Comorbidities
errDIABETES CARE
IF16.6
err2022-12-22
err2
errOAAI
errHoogwerf, Byron J.
err分享
err收藏
Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus
errENDOCRINE PRACTICE
IF4.6
err2021-05-01
err14
errOAAI
errLevin, Philip; Hoogwerf, Byron J.; Snell-Bergeon, Janet; Vigers, Tim; Pyle, Laura; Bromberger, Lee
err分享
err收藏
Results of a 24-Week Trial of Technosphere Insulin Versus Insulin Aspart in Type 2 Diabetes
errENDOCRINE PRACTICE
IF4.6
err2021-01-01
err11
errOAAI
errHoogwerf, Byron J.; Pantalone, Kevin M.; Basina, Marina; Jones, Marisa C.; Grant, Marshall; Kendall, David M.
err分享
err收藏
Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus
errJOURNAL OF DIABETES
IF3.7
err2020-09-04
err10
PREAI
errMcGill, Janet B.; Weiss, Daniel; Grant, Marshall; Jones, Marisa C.; Kendall, David M.; Hoogwerf, Byron J.
err分享
err收藏
Hypoglycemia in Older Patients
errCLINICS IN GERIATRIC MEDICINE
IF3.9
err2020-08-01
err4
PREAI
errHoogwerf, Byron J.
err分享
err收藏
Dose Titration and Clinical Effects of Inhaled Technosphere Insulin Compared with Mealtime Subcutaneous (SC) Analog Insulin Therapy in Type 1 Diabetes (T1D)
errDIABETES
IF7.5
err2020-06-01
err0
PREAI
errKendall, David M.; Manoukian, Jonathan; Krueger, John A.; Jones, Marisa; Abaniel, Richard; Morey, Patrick M.; Grant, Marshall L.; Hoogwerf, Byron J.
err分享
err收藏
Technosphere Insulin Added to Basal Insulin Is Associated with Less Weight Gain than Basal Insulin plus Insulin Aspart or Insulin Analog (Aspart) 70/30 Mixture in Type 2 DM
errDIABETES
IF7.5
err2020-06-01
err0
PREAI
errManoukian, Jonathan; Kendall, David M.; Morey, Patrick M.; Hoogwerf, Byron J.
err分享
err收藏
Incidence of Significant Changes in Pulmonary Function during a 2-Year Study with Inhaled Technosphere Insulin
errDIABETES
IF7.5
err2020-06-01
err0
PREAI
errJones, Marisa C.; Tran, Tiffany S.; Krueger, John A.; Morey, Patrick M.; Hoogwerf, Byron J.; Kendall, David M.
err分享
err收藏
Type of diabetes mellitus: Does it matter to the clinician?
errCLEVELAND CLINIC JOURNAL OF MEDICINE
IF4.1
err2020-02-03
err6
errOAAI
errHoogwerf, Byron J.
err分享
err收藏
Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study
errJOURNAL OF THE AMERICAN HEART ASSOCIATION
IF5.3
err2018-05-15
err6
errOAAI
errTang, W. H. Wilson; McGee, Paula; Lachin, John M.; Li, Daniel Y.; Hoogwerf, Byron; Hazen, Stanley L.
err分享
err收藏
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
errclinical epidemiology
IF3.2
err2017-12-01
err40
errOAAI
errSimeone, Jason C.; Bae, Jay P.; Hoogwerf, Byron J.; Li, Qian; Haupt, Axel; Ali, Ayad K.; Boardman, Marilyn K.; Nordstrom, Beth L.
err分享
err收藏
Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database
errCLINICAL THERAPEUTICS
IF3.6
err2017-09-01
err14
errOAAI
errBae, Jay P.; Duan, Ran; Fu, Haoda; Hoogwerf, Byron J.
err分享
err收藏
Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
errDIABETES OBESITY & METABOLISM
IF5.7
err2017-06-22
err151
PREAI
errCusi, Kenneth; Sanyal, Arun J.; Zhang, Shuyu; Hartman, Mark L.; Bue-Valleskey, Juliana M.; Hoogwerf, Byron J.; Haupt, Axel
err分享
err收藏
The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2017-06-06
err4
errOAAI
errOrchard, Trevor J.; Cariou, Bertrand; Connelly, Margery A.; Otvos, James D.; Zhang, Shuyu; Antalis, Caryl J.; Ivanyi, Tibor; Hoogwerf, Byron J.
err分享
err收藏
Similar HbA1c reduction and hypoglycaemia with variable- vs fixed-time dosing of basal insulin peglispro in type 1 diabetes: IMAGINE 7 study
errDIABETES OBESITY & METABOLISM
IF5.7
err2016-10-10
err6
errOAAI
errGarg, S.; Selam, J-L.; Bhargava, A.; Schloot, N.; Luo, J.; Zhang, Q.; Jacobson, J. G.; Hoogwerf, B. J.
err分享
err收藏
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes
errDIABETES OBESITY & METABOLISM
IF5.7
err2016-10-10
err30
errOAAI
errCusi, K.; Sanyal, A. J.; Zhang, S.; Hoogwerf, B. J.; Chang, A. M.; Jacober, S. J.; Bue-Valleskey, J. M.; Higdon, A. N.; Bastyr, E. J., III; Haupt, A.; Hartman, M. L.
err分享
err收藏
Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials
errDIABETES OBESITY & METABOLISM
IF5.7
err2016-09-14
err16
PREAI
errGinsberg, Henry; Cariou, Bertrand; Orchard, Trevor; Chen, Lei; Luo, Junxiang; Bastyr, Edward J., III; Bue-Valleskey, Juliana; Chang, Annette M.; Ivanyi, Tibor; Jacober, Scott J.; Hoogwerf, Byron J.
err分享
err收藏
Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications
errDIABETES CARE
IF16.6
err2016-07-16
err9
errOAAI
errHoogwerf, Byron J.; Manner, David H.; Fu, Haoda; Moscarelli, Elena; Gaydos, Brenda L.; Heine, Robert J.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
S
Salim Yusuf
H 指数: 265 · 论文数: 2.2K
A
Arun J. Sanyal
H 指数: 166 · 论文数: 1.4K
S
Stanley L. Hazen
H 指数: 151 · 论文数: 757
E
Eugene H. Blackstone
H 指数: 147 · 论文数: 1.0K
J
John B. Buse
H 指数: 142 · 论文数: 1.1K
查看更多